Clinical and Research Evidence for Management of COVID-19 Patients

  1. Critical Care and COVID-19 Presentations and Webinars
  2. Care for Critically Ill Patients with COVID-19 by Murthy et al JAMA 2020
  3. Treatment for Severe Acute Respiratory Distress Syndrome for COVID-19 by Matthay et al Lancet Respiratory Medicine 2020
  4. COVID-19 pneumonia: Different respiratory treatment for different phenotypes? (Gattinoni L et al ICM 2020)
  5. Severe COVID-19” (Berline DA et al NEJM 2020)
  6. Low Tidal Volume Ventilation in ARDS
  7. PEEP Titration in ARDS
  8. Neuromuscular blockage in ARDS
  9. Prone Positioning for Severe COVID-19 (ARDS)
  10. Conservative Fluid Management in ARDS
  11. Inhaled Pulmonary Vasodilators
  12. Extracorporeal Life Support in ARDS
  13. Corticosteroids
    1. Efficacy and safety of corticosteroids in COVID-19 based on evidence for
      COVID-19, other coronavirus infections, influenza, community-acquired
      pneumonia and acute respiratory distress syndrome: a systematic review and
      meta-analysis (Ye Z et al CMAJ 2020)

    2. Corticosteroid therapy for critically ill patients with Middle East Respiratory
      Syndrome (Arabi YM et al Am J Resp Crit Care Med 2018)

    3. Corticosteroids as adjunctive therapy in the treatment of influenza (Rodrigo C
      et al Cochrane Database Syst Rev 2016)

    4. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death
      in Patients with COVID-19 in Wuhan, China (Wu C et al JAMA Internal Med

    5. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung
      injury” (Russell CD et al Lancet 2020)